Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for Failure to Thrive in Children
NCT01314989Phase 4Unknown
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Dec 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyproheptadine in failure to thrive (FTT), sponsored by Centre Hospitalier Universitaire Sainte-Justine. Status: unknown.
02
Drugs
cyproheptadine
03
Conditions
failure to thrive (FTT)
Beyond the preview
Go deeper on NCT01314989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314989.